The feasibility study on continuous 7-day-a-week external beam irradiation in locally advanced cervical cancer: A report on acute toxicity

Radiotherapy and Oncology

Volumn 61, Issue 2, 2001, Pages 197-202

  Serkies, Krystyna ^a   Kobierska, Anna ^a   Konopa, Krzysztof ^a   Sawicki, Tomasz ^a   Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cervix carcinoma; Continuous accelerated irradiation; Normal tissue reactions

Indexed keywords

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EVALUATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; IRRADIATION; PELVIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TREATMENT OUTCOME; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA;

ADULT; AGED; BRACHYTHERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY DOSAGE; UTERINE CERVICAL NEOPLASMS;

EID: 0034748970     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(01)00420-0     Document Type: Article

References (24)

1. The effect of treatment duration in local control of cervix cancer
2. Overall treatment time in advanced cervical carcinoma: A critical parameter in treatment outcome
3. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial
4. A pilot study of concomitant boost accelerated superfractionated radiotherapy for stage III cancer of the uterine cervix
5. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
6. Twice-daily fractionation of external irradiation with brachytherapy in bulky carcinoma of the cervix
7. Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix
8. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study
9. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity
10. 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer
11. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
12. Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix
13. Quantification of treatment toxicity
14. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy
15. The adverse effect of treatment prolongation in cervical carcinoma
16. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
17. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multicentre trial
18. Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: Acute reactions of skin and mucosa
19. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer: Report on three year tumour control and normal tissue toxicity
20. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: Evidence suggestive of consequential late effect (CQLE)
21. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: Patterns of fractionation study of radiobiology
22. The hazard of accelerated tumour clonogen repopulation during radiotherapy
23. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study
24. Hyperfractionation in advanced carcinoma of uterine cervix: A preliminary report